SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nord who wrote (1106)10/10/1998 11:27:00 PM
From: MJ  Read Replies (3) of 1510
 
Nord

Is it possible that the IMNR treatment for AIDS could be the opening of the door for treating other viruses in a similar fashion. Or even a bridge to treating other diseases whose end results are similar in nature---i.e. the breakdown of the autoimmune system. If so, this stock could be a winner on many levels.

A second question ---is AIDS a new disease of this late century or is it a disease such as polio which according to a recent documentary is thought to be centuries old and became prevalent in the early part of this century and later in the 1950's in this country as we began to improve sanitation.

My understanding is that with the improvment of sanitation---young children who normally played in the streets were no longer exposed to the filth and their immune systems did not develope immunity as did the children who had played in the streets and gutters in previous years.

mj
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext